Cell signaling pathways. Cell signaling pathways can be disrupted in CLL cells by activating mutations of NOTCH1 or loss of one allele of BIRC3 by deletion (11q22.2) or mutation. In addition, BCR signaling can be increased in cells with non-mutated or stereotypic IGHV usage. One common feature of these pathways is their ability to activate NF-κB.